Can ketamine be a safe option for treatment-resistant bipolar depression?

Balwinder Singh, Jennifer L. Vande Voort, Mark A. Frye, Simon Kung

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
JournalExpert Opinion on Drug Safety
StateAccepted/In press - 2022


  • Ketamine
  • bipolar disorders
  • treatment-resistant bipolar depression

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this